Treatment (pg/ml) | LDH Release (% of glutamate alone group) | MTT Reduction (% of glutamate alone group) |
---|---|---|
Control | 41.59 ± 2.85*** | 194.49 ± 3.52*** |
Glutamate alone | 100.00 ± 1.25 | 100.00 ± 1.51 |
17α-estradiol (10) | 83.03 ± 1.91** | 98.06 ± 1.39 |
17β-estradiol (10) | 92.29 ± 1.91** | 98.81 ± 1.93 |
Equilin (1000) | 86.37 ± 2.19** | 105.76 ± 3.36 |
Equilenin (300) | 88.00 ± 2.55** | 103.62 ± 1.86 |
17α-dihydroequilin (1000) | 90.68 ± 2.21** | 102.22 ± 2.25 |
17α-dihydroequilenin (27) | 84.74 ± 3.02** | 91.10 ± 5.63 |
17β-dihydroequilenin (27) | 90.87 ± 2.99* | 113.17 ± 3.65 |
Δ8,9-dehydroestrone (300) | 86.69 ± 2.20** | 102.88 ± 2.71 |